| scholarly article | Q13442814 |
| P50 | author | Michael Allison | Q47724942 |
| David J Lomas | Q56613432 | ||
| P2093 | author name string | D Bilton | |
| Graeme J M Alexander | |||
| C S Haworth | |||
| K L Nash | |||
| D McKeon | |||
| P433 | issue | 3 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| liver disease | Q929737 | ||
| P304 | page(s) | 252-257 | |
| P577 | publication date | 2007-11-26 | |
| P1433 | published in | Journal of Cystic Fibrosis | Q15749341 |
| P1476 | title | A single centre experience of liver disease in adults with cystic fibrosis 1995-2006 | |
| P478 | volume | 7 |
| Q37800159 | A review of abdominal organ transplantation in cystic fibrosis |
| Q50717522 | Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity. |
| Q33757918 | Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study |
| Q35561131 | Cholic acid induces a Cftr dependent biliary secretion and liver growth response in mice |
| Q35920464 | Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process |
| Q37637314 | Imaging the Abdominal Manifestations of Cystic Fibrosis |
| Q57651838 | Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy |
| Q37628124 | Incidence and clinical significance of elevated liver function tests in cystic fibrosis clinical trials. |
| Q33839732 | Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data |
| Q83567234 | Liver: Benefit of liver transplantation in patients with cystic fibrosis |
| Q49078988 | Longitudinal Transient Elastography Measurements Used in Follow-up for Patients with Cystic Fibrosis |
| Q36197335 | Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode. |
| Q30465393 | Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores |
| Q84800550 | Outcome in Cystic Fibrosis Liver Disease |
| Q38234646 | Progress towards next-generation therapeutics for cystic fibrosis |
| Q44470769 | Proteinuria in cystic fibrosis: a possible correlation between genotype and renal phenotype |
| Q45146722 | Pulmonary function in individuals who underwent liver transplantation: from the US cystic fibrosis foundation registry |
| Q42046506 | Relevance of 3D Cholangiography and Transient Elastography to Assess Cystic Fibrosis-Associated Liver Disease? |
| Q49334378 | Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease |
| Q84237004 | Routine OGTT screening for CFRD - no thanks |
| Q38664567 | Serum Phospholipid Fatty Acid Composition in Cystic Fibrosis Patients with and without Liver Cirrhosis. |
| Q48190174 | Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice |
Search more.